Two new malaria drugs show promise as drug after study in 12 African countries
Novartis’ GanLum is a combination of a new drug, ganaplacide and an existing long-acting medication, lumefantrine.
Novartis’ GanLum is a combination of a new drug, ganaplacide and an existing long-acting medication, lumefantrine.

Feel free to get in touch with us.
Regarding news, email: editor@tell.co.ke
For all others, email: info@tell.co.ke
News you can trust
Tell is a totally independent Kenyan-based news and current affairs media house. Tell delivers in-detail journalism for critical audiences interested in finance/economy, humanity, progress and governance.
We are seasoned journalists story-telling in written format and recorded/produced/digital media.
